Brian Jonas

39PUBLICATIONS
93CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Apr 09, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Razan Mohty, Ravi Narra, Alice S Mims

|Sep 05, 2025
Outcomes of patients treated with venetoclax plus azacitidine versus azacitidine alone stratified by advanced age and acute myeloid leukemia composite model.

Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux

|Feb 10, 2025
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.

Athalia R Pyzer, Laura W Dillon, Elad Sharon

|Dec 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial.

Caspian Oliai, Sunmin Park, Lloyd E Damon

|Sep 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort.

Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri

|Sep 10, 2024
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study.

Talha Badar, Ravi Narra, Alice S Mims

Pageof 7

Frequent Collaborators

9 joint publications

Courtney DiNardo

7 joint publications

Christian Recher

7 joint publications

Keith W Pratz

5 joint publications

Jacqueline S Garcia